Proshares Trust ZBIO
ZBIO
$28.08 -0.10 (-0.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) Total Non-Current Liabilities (2024 - 2026)

Updated

Zenas BioPharma's Total Non-Current Liabilities was $388.78 million in Q2 2026, up 10.9% from the prior quarter.

Analysis

Zenas BioPharma (ZBIO) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Zenas BioPharma came in at $78.85 million.

  • In earlier years, Total Non-Current Liabilities was $218,000 in FY2024.
  • Per Business Quant data, ZBIO's Total Non-Current Liabilities in the three quarters before Q2 2026 was $350.69 million (Q1 2026), $78.85 million (Q4 2025) and $73.17 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Zenas BioPharma 1.77 Bn 1.09 Bn - 388.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 388.78 Mn
Mar 31, 2026 350.69 Mn
Dec 31, 2025 78.85 Mn
Sep 30, 2025 73.17 Mn
Dec 31, 2024 218,000.00
API Access

Zenas BioPharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ZBIO&period=max&api_key=YOUR_API_KEY